Beijing Strong Biotechnologies Inc
SZSE:300406
Beijing Strong Biotechnologies Inc
Operating Income
Beijing Strong Biotechnologies Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Strong Biotechnologies Inc
SZSE:300406
|
Operating Income
¥618.5m
|
CAGR 3-Years
59%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥12B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Operating Income
¥2B
|
CAGR 3-Years
32%
|
CAGR 5-Years
23%
|
CAGR 10-Years
22%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥9.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
47%
|
See Also
What is Beijing Strong Biotechnologies Inc's Operating Income?
Operating Income
618.5m
CNY
Based on the financial report for Dec 31, 2023, Beijing Strong Biotechnologies Inc's Operating Income amounts to 618.5m CNY.
What is Beijing Strong Biotechnologies Inc's Operating Income growth rate?
Operating Income CAGR 5Y
13%
Over the last year, the Operating Income growth was 26%. The average annual Operating Income growth rates for Beijing Strong Biotechnologies Inc have been 59% over the past three years , 13% over the past five years .